&Partners’s Celgene Corp CELG Stock Holding History

&Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,880	Closed	-$286K	–	174
2019 Q3	$286K	Hold	2,880	–	–	0.37%	98
2019 Q2	$266K	Sell	2,880 -115	-4%	-$10.9K	0.37%	91
2019 Q1	$283K	Buy	+2,995	New	+$262K	0.41%	89

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

&Partners's CELG Position: Q4 2019 in Review

&Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,880 shares — an estimated $286K sold.

&Partners first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $286K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

&Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
&Partners sold 2,880 Celgene Corp shares in Q4 2019, an estimated $286K.
&Partners first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
&Partners's Celgene Corp position peaked at $286K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on &Partners's 13F filing for Q4 2019, filed 10 Jan 2020.